We're a long way from being a standalone oncology company, but, the pieces are coming together to make that a reality. Just imagine for a moment in 2011, we have successful Rida results and the filing of the NDA, we have additional successful data on Pona (late 2011), and the first details are revealed on the structure of the first clinical trial of '113. Wow...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.